Evidence map›Paper›PMID 40066208›Full record

ArticleEFSA journal. European Food Safety Authority2025

Assessment of fall-back MRLs for revoked CXLs previously implemented in the EU legislation.

European Food Safety Authority (EFSA)

Abstract read
In one paragraph

Article in EFSA journal. European Food Safety Authority, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Article
  2. Article
  3. Review
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

1 author.

European Food Safety Authority (EFSA)

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

In the 55th meeting of the Codex Committee on Pesticide Residues (CCPR meeting) held in June 2024 and the subsequent 47th meeting of the Codex Alimentarius Commission (CAC) (November 2024), in total 111 Codex MRLs (CXLs) for 16 active substances (a.s.) were revoked. In accordance with Article 43 of Regulation (EC) 396/2005, EFSA was requested by the European Commission to identify the revoked CXLs which had been previously taken over in the EU MRL legislation (Regulation (EC) No 396/2005) and, if possible, propose fall-back maximum residue levels (MRLs) to replace the revoked CXLs. Based on the detailed assessment and taking into account the information provided by Member States, EFSA proposed fall-back MRLs for carbofuran in cotton seed and fluopyram/wheat. Risk management discussions are recommended to decide on the appropriate fall-back option for cyantraniliprole in soya beans. For difenoconazole, EFSA proposed to postpone the decision on a possible fall-back MRL, pending the outcome of the ongoing review of EU MRLs. For imazapyr/wheat and cyantraniliprole/beans and eggs, the existing MRLs will be replaced by new CXLs. The revocation of the other CXLs does not trigger a modification of the existing EU MRLs.

Indexed as

consumer risk assessmentrevoked codex MRLs

Identifiers

PMID40066208
PMCPMC11891565

What OpenQuestion holds

Textmetadata
LicenceCC BY-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.